Glukoza (Glucosum Anhydricum Fp) Pph Microfarm (Glucose)

Glukoza (Glucosum Anhydricum Fp) Pph Microfarm is a pharmaceutical-grade glucose product supplied by Pph Microfarm. The active ingredient is glucose, anhydrous form, presented as an oral excipient without a specified strength or dosage form. Originating from the European Union, Glukoza is used primarily as a carbohydrate source in compounding and as a vehicle for oral formulations. It is classified as an excipient rather than a therapeutic drug.

Glukoza serves as a non‑medicinal component in a variety of pharmaceutical and nutritional preparations, providing a readily absorbable source of carbohydrate.

- As a filler or diluent in oral tablets and capsules. - As a sweetening agent in syrups, suspensions, and chewable formulations. - To adjust osmolarity in parenteral nutrition solutions. - As a substrate in in‑vitro diagnostic assays that require glucose. - For compounding pediatric or geriatric formulations where rapid energy supply is needed. - As a stabilizing carbohydrate in freeze‑dry (lyophilized) vaccine preparations. - To support cell culture media formulations that require defined glucose concentrations.

Glukoza, when ingested as part of a formulation, generally exhibits a safety profile consistent with dietary glucose, but adverse reactions can still occur in susceptible individuals.

Common: - Mild gastrointestinal discomfort such as bloating or flatulence. - Transient increase in blood glucose levels in individuals without diabetes. - Slight nausea when consumed in large quantities. - Temporary sweet taste perception leading to increased desire for sugary foods. - Mild headache reported by some individuals after rapid glucose absorption.

Serious: - Hypersensitivity reactions including rash, itching, or urticaria. - Severe hyperglycemia in patients with uncontrolled diabetes. - Rare cases of anaphylaxis reported with excipient contamination. - Potential for osmotic diarrhea when administered in high concentrations.

When incorporating Glukoza into pharmaceutical or nutritional products, several precautionary measures should be observed to ensure safety and product quality.

- Verify the glucose purity to avoid contamination with microbial or chemical impurities. - Assess the patient’s glycemic status, especially in diabetic or pre‑diabetic populations. - Limit the amount of Glukoza in formulations intended for infants or individuals with impaired glucose tolerance. - Store the product in a dry, cool environment to prevent moisture uptake and clumping. - Avoid using Glukoza in products requiring strict low‑carbohydrate content, such as ketogenic diets. - Ensure compatibility with other excipients to prevent unexpected chemical reactions. - Document the source and batch number for traceability in regulated manufacturing.

Glukoza may influence the performance of other substances when combined in a formulation or taken concurrently, and certain interactions warrant attention.

Avoid: - Co‑administration with high‑dose insulin or other rapid‑acting glucose‑lowering agents without medical supervision. - Mixing with acidic excipients that can promote caramelization and alter product stability.

Use with caution: - Concurrent use with medications that have a narrow therapeutic index and are affected by blood glucose fluctuations, such as certain antiepileptics. - Formulations containing other sugars, which may increase overall carbohydrate load and affect caloric calculations. - Use in patients receiving parenteral nutrition where glucose infusion rates must be carefully balanced.